BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Spinraza (nusinersen): communicating hydrocephalus not related to meningitis or bleeding reported

Active substance: nusinersen

The marketing authorization holder, Biogen, informs of the occurrence of communicating hydrocephalus not related to meningitis or bleeding under treatment with Spinraza. Biogen informs on several measures that should be followed.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 306KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK